Coderre Mandy, Fortin Ann-Sophie, Morency Louis-David, Roy Juliette, Sirois Caroline
Faculté de pharmacie, Université Laval, Québec, Canada.
Centre d'excellence sur le vieillissement de Québec, VITAM- Centre de recherche en santé durable, Québec, Canada.
Int J Pharm Pract. 2025 Jul 24;33(4):360-368. doi: 10.1093/ijpp/riaf038.
To summarize knowledge on medications and medication-disinfection byproducts-compounds formed when pharmaceutical contaminants react with disinfectants-found in drinking water and its sources (effluents, surface water, groundwater), aiming to raise awareness and empower pharmacists to implement best practices for improving public health and reducing environmental impact.
A scoping review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Data were retrieved from Medline and Embase between 2005 and 2023 using keywords related to drinking water, pharmaceutical waste, and water purification. Articles had to focus on human medication use and originate from North America and Europe. Data on types of medications, concentrations found in drinking water or its sources, and types of byproducts were extracted, and a narrative synthesis was written.
Forty-five articles were included. Among pre-defined classes, antihypertensives, analgesics, antibiotics, and psychotropic medications were most frequently found. The most commonly identified medications included carbamazepine, diclofenac, ibuprofen, and acetaminophen/paracetamol. Traces of medications were present in many water sources, with higher concentrations near pharmaceutical industries. Some medications, like carbamazepine, persist in the environment for extended periods. Although not necessarily found in drinking water, medication-disinfection byproducts can be toxic, and further evidence is required to assess their risk.
Many medications are found in drinking water and its sources, highlighting the need for pharmacists to consider their public health impact. Best practices, such as prescribing only when necessary, deprescribing, social/green prescribing, and opting for environmentally friendly alternatives, should be enforced.
总结关于饮用水及其来源(废水、地表水、地下水)中药物以及药物与消毒剂反应形成的药物消毒副产物化合物的知识,旨在提高认识并使药剂师能够实施最佳实践,以改善公众健康并减少环境影响。
根据系统评价和Meta分析扩展版的系统评价优先报告项目进行了一项范围综述。2005年至2023年间,使用与饮用水、药物废物和水净化相关的关键词从Medline和Embase中检索数据。文章必须聚焦于人类用药情况,且源自北美和欧洲。提取了关于药物类型、在饮用水或其来源中发现的浓度以及副产物类型的数据,并撰写了叙述性综述。
纳入了45篇文章。在预定义类别中,抗高血压药、镇痛药、抗生素和精神药物最为常见。最常识别出的药物包括卡马西平、双氯芬酸、布洛芬和对乙酰氨基酚。许多水源中都存在微量药物,在制药行业附近浓度更高。一些药物,如卡马西平,在环境中持续存在很长时间。虽然不一定在饮用水中发现,但药物消毒副产物可能有毒,需要进一步证据来评估其风险。
在饮用水及其来源中发现了许多药物,这凸显了药剂师考虑其对公众健康影响的必要性。应实施最佳实践,如仅在必要时开药、减药、社会/绿色开药以及选择环保替代品。